Medical Properties Trust, Inc. (MPT)

NYSE: MPT · USD

$2.75

+0.03 (+0.9%)· Recorded snapshot

Market cap	1.6B
Revenue (ttm)	1.1B
Net income (ttm)	-31.6M
EPS (ttm)	-$0.05
Shares out	597.2M
P/E (forward)	34.4x
Dividend	$0.36 (13.07%)
Volume	10,147,478
Beta	1.49

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.1B
Net income (ttm): -31.6M
EPS (ttm): -$0.05
P/E (forward): 34.4x
Market cap: 1.6B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AMT	American Tower Corporation	85.1B	25.8x	7.5x	7.8%	+4.0%	+0.7%	Ridurre
ARE	Alexandria Real Estate Equities Inc.	6.9B	—	2.4x	0.9%	+6.6%	-45.8%	Mantenere
CCI	Crown Castle Inc.	37.4B	46.3x	9.1x	5.1%	-7.9%	-6.2%	Vendere

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E34.4

P25 11.8P50 26.8P75 44.2

Trailing P/En/a

P25 14P50 22.5P75 42.8

ROE-0.6

P25 -2P50 3.9P75 8.9

ROIC4.7

P25 0.5P50 2.5P75 4.8

Benchmarks · 1M

All MPT indicators

Market & fundamental data

Available fields

242

Groups with data

Currency

USD

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001287865
Company name	Medical Properties Trust, Inc.
Country	United States
Country code	US
CUSIP number	58463J304
Earnings date	2026-10-29
Earnings time	bmo
Employees	121
Employees change	3
Employees growth	2.54%
Enterprise value	$10.9B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2003
Industry	REIT - Healthcare Facilities
Is primary listing	Yes
Is SPAC	No
ISIN number	US58463J3041
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.6B
Market cap category	Small-Cap
Next earnings date	2026-10-29
Options	Yes
Price	$2.75
Price currency	USD
Sector	Real Estate
Stock price date	2026-10-28
Symbol	MPT
U.S. state	Alabama
Website	https://www.medicalpropertiestrust.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	19.05x
Earnings yield	-1.92%
EV/EBIT	16.49x
EV/EBITDA	11.52x
EV/FCF	65.33x
EV/Sales	9.89x
FCF / EV yield	1.53%
FCF yield	10.33%
Forward EV/Sales	10.24x
Forward P/E	34.44x
Forward P/S	1.52x
Industry forward P/E	66.06x
Industry P/E	78.26x
P/(FCF - SBC) ratio	10.47x
P/(OCF - SBC) ratio	7.56x
P/B ratio	0.36x
P/FCF ratio	9.68x
P/OCF ratio	7.14x
P/S ratio	1.46x
PEG ratio	11.33x
Price / tangible book value	0.36x
Price/EBITDA ratio	1.71x
Sector forward P/E	29.99x
Sector P/E	40.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	59.97%
EBITDA margin	85.87%
FCF margin	15.14%
Gross margin	95.94%
Operating margin	59.97%
Pretax margin	-2.93%
Profit margin	-2.73%
Profit per employee	$-261,165
Revenue per employee	$9.1M
ROA	2.77%
ROA (5Y)	2.28%
ROCE	5.09%
ROE	-0.62%
ROE (5Y)	-6.48%
ROIC	4.66%
ROIC (5Y)	3.59%
SBC / revenue	1.15%
Tax / revenue	-0.3%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	7
EPS growth years	1
Net income growth quarters	7
Net income growth years	1
OCF growth	20.64%
OCF growth (Q)	20.67%
OCF growth 10Y	-1.24%
OCF growth 3Y	-27.98%
OCF growth 5Y	-20.04%
Revenue growth	12.09%
Revenue growth (Q)	1.89%
Revenue growth (QoQ)	1.08%
Revenue growth 10Y	8.15%
Revenue growth 3Y	-8.93%
Revenue growth 5Y	-5.07%
Revenue growth quarters	4
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-59.6M
Depreciation and amortization	$273.3M
EBIT	$662.7M
EBITDA	$948.8M
EPS	$-0.05
FCF per share	$0.28
Financing cash flow	$-75M
Free cash flow	$167.3M
Free cash flow minus SBC	$154.6M
Funds from operations (FFO)	$415.3M
Gross profit	$1.1B
Income taxes	$-3.4M
Investing cash flow	$-262.1M
Net cash flow	$-113.5M
Net income	$-31.6M
Operating cash flow minus SBC	$214.2M
Operating income	$662.7M
Revenue	$1.1B
Stock-based compensation	$12.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$7.54
Debt / EBITDA	10.21
Debt / equity	2.16
Debt / FCF	58.03
Interest coverage	1.24
Net cash (debt)	$-9.3B
Net cash / market cap	-575.16%
Net debt / EBITDA	9.81
Net debt / equity	2.07
Net debt / FCF	55.65
Piotroski F-Score	4
Property, plant and equipment	$10.4B
Shareholders' equity	$4.5B
Tangible book value	$4.5B
Tangible book value per share	$7.54
Total assets	$14.7B
Total cash	$396.6M
Total debt	$9.7B
Total liabilities	$10.2B
WACC	5.5%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.07
Current ratio	1.17
Net working capital	$1.2B
Quick ratio	1
Working capital	$295.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.18%
Dividend growth	12.5%
Dividend growth (10Y)	-8.76%
Dividend growth (3Y)	-29.33%
Dividend growth (5Y)	-20.16%
Dividend growth years	0
Dividend payment date	2026-10-08
Dividend payment years	22
Dividend payout frequency	Quarterly
Dividend per share	$0.36
Dividend yield	13.07%
Ex-dividend date	2026-09-10
FCF payout ratio	128.54%
Last dividend	$0.09
Shareholder yield	13.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-80.43%
10Y return CAGR	-8.53%
10Y total return	-59.01%
150-day SMA	$4.37
15Y price change	-73.68%
15Y return CAGR	-1.67%
15Y total return	-22.29%
1D price change	0.92%
1M price change	-23.11%
1M total return	-23.11%
1W price change	0.18%
1W total return	0.18%
1Y price change	-46.49%
1Y return CAGR	-42.21%
1Y total return	-42.18%
20-day SMA	$3.01
200-day SMA	$4.59
20Y price change	-79.51%
20Y return CAGR	-0.22%
20Y total return	-4.29%
3M price change	-42.69%
3M total return	-41.34%
3Y price change	-43.98%
3Y return CAGR	-10.37%
3Y total return	-27.99%
50-day SMA	$3.49
50-day SMA vs 200-day SMA	50under200
52-week high	$6.47
52-week high date	2026-02-19
52-week low	$2.61
52-week low date	2026-10-22
5Y price change	-87.11%
5Y return CAGR	-27.65%
5Y total return	-80.17%
6M price change	-46.49%
6M total return	-44.17%
All-time high	$24.29
All-time high date	2020-02-18
All-time low	$2.61
All-time low date	2026-10-21
Average true range (ATR)	$0.14
Average volume	13.8M
Beta (1Y)	1.18
Beta (2Y)	1.03
Beta (5Y)	1.49
Change from 52-week high	-57.57%
Change from 52-week low	5.17%
Change from all-time high	-88.7%
Change from all-time low	5.17%
Change from open	1.67%
Day's gap	-0.74%
Dollar volume	$27.9M
High price	$2.78
Low price	$2.65
Monthly RSI	34.3
Open price	$2.70
Position in 52-week range	76.92%
Premarket change	0.37%
Premarket close	$2.72
Premarket price	$2.73
Premarket volume	14.5K
Previous close	$2.72
Price vs 150-day SMA	-37.13%
Price vs 20-day SMA	-8.74%
Price vs 200-day SMA	-40.16%
Price vs 50-day SMA	-21.26%
Relative volume	0.74
RSI	30.01
Sharpe ratio	-1.37
Sharpe ratio (3Y)	0.05
Sharpe ratio (5Y)	-0.46
Sortino ratio	-1.73
Sortino ratio (3Y)	0.18
Sortino ratio (5Y)	-0.55
Volume	10.1M
Weekly RSI	23.1
YTD price change	-45.1%
YTD total return	-41.65%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	489.9M
Float percentage	82.04%
Shares change (QoQ)	0.04%
Shares change (YoY)	-0.18%
Shares held by insiders	17.9%
Shares held by institutions	61.05%
Shares outstanding	597.2M
Short % of float	29.84%
Short % of shares	24.48%
Short ratio	13.2 days

Deeper analysis on MPT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this MPT report

Is a complete MPT research report available?

No complete published report is available for Medical Properties Trust, Inc. (MPT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Medical Properties Trust, Inc. (MPT)

Price

Financial snapshot

Fair-value bridge

Latest news · MPT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MPT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MPT

Frequently asked questions